Acquilion one

Manufactured by Toshiba

Sourced in Japan

The Aquilion ONE is a computed tomography (CT) scanner developed by Toshiba. It is designed to capture high-quality images of the body's internal structures. The Aquilion ONE utilizes advanced technology to provide detailed, three-dimensional visualizations of the patient's anatomy.

Automatically generated - may contain errors

Lab products found in correlation

Magnetom verio tim, by Siemens (1 mentions) Ge discovery ct750 hd, by GE Healthcare (1 mentions) Lightspeed ultra, by GE Healthcare (1 mentions) Brilliance 64, by Philips (1 mentions) Vitrea version 6, by Toshiba (1 mentions)

4 protocols using acquilion one

Cerebral Vasospasm Diagnosis Using CTA and MRA

Check if the same lab product or an alternative is used in the 5 most similar protocols

Detection of cerebral vasospasm using computed tomography angiography (CTA) (Acquilion ONE, Toshiba Medical Systems, Nasu, Japan) or 3.0 T three-dimensional time-of-flight (TOF) MRA (Magnetom Verio Tim, Siemens, Erlangen, Germany; or another system: Skyra; Siemens, Erlangen, Germany) was performed for all patients.
Two neurosurgeons, blinded to the patient’s pre- and post-operative medical history, performed analysis using CTA/MRA. When a new infarction on diffusion-weighted imaging was not immediately visible after operation and clinical deterioration/neurological deficit attributable to vascular narrowing was found on MRA, CTA, or digital subtraction angiography (DSA), it was defined as SCV.
At pre-operation and the first day post-operation, CTA/MRA was performed, and again at every 3 to 7 days until day 30, based on the decision made by the neurosurgeon and neurocritical care physician. If CV was identified, daily transcranial Doppler sonography, CTA, or MRA was performed until CV was resolved. DSA was performed if CV was suspected and CTA/MRA became unsuitable for analyzing the spasm or endovascular treatment was necessary.

Ding C.Y., Wang F.Y., Cai H.P., Chen X.Y., Zheng S.F., Yu L.H., Lin Y.X., Lin Z.Y, & Kang D.Z. (2020). Can admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage?. Chinese Neurosurgical Journal, 6, 9.

+ Open protocol

+ Expand

Multidetector CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Chest CT scans were performed using seven different multidetector CT systems (Acquilion ONE, Toshiba Medical Systems, Otawara, Japan; Somatom Definition and Sensation 16, Siemens Medical Solutions, Forchheim, Germany; Brilliance 64 and Ingenuity, Philips Healthcare, Cleveland, OH, USA; LightSpeed Ultra and GE Discovery CT 750 HD, GE Healthcare, Milwaukee, WI, USA) due to the retrospective nature of our study. All CT scans were obtained with automatic tube current modulation at a tube voltage of 120 kV, pitch of 1, and rotation time of 0.5 seconds. Axial images were reconstructed with a 1 or 1.25 mm section thickness and coronal images with a 3 mm section thickness. The mean effective dose was 4 mSv.

Lee K.H., Goo J.M., Lee S.M., Park C.M., Bahn Y.E., Kim H., Song Y.S, & Hwang E.J. (2015). Digital Tomosynthesis for Evaluating Metastatic Lung Nodules: Nodule Visibility, Learning Curves, and Reading Times. Korean Journal of Radiology, 16(2), 430-439.

+ Open protocol

+ Expand

CT Imaging of BNF-lip Tumor Distribution

Check if the same lab product or an alternative is used in the 5 most similar protocols

All VX2 tumour-bearing rabbits were imaged in a clinical wide-detector X-ray CT scanner (Acquilion ONE, Toshiba, Tokyo, Japan) with and without contrast medium, at baseline, 48 h (4) or 7 days (6) post-intra-arterial injection. CT scanning of the liver was performed to determine whether imaging of intratumoural distribution of injected BNF-lip was feasible. For imaging the liver and tumour with CT, the following parameters were used: 120 kV tube voltage; 80 mA tube current; 0.5 s gantry revolution time; 1 mm pixel spacing; 512 × 512 pixel (spatial resolution); and 0.5 mm reconstructed slice thickness. First, an unenhanced scan was performed. Second, dynamic CT scanning was initiated with a scan delay time of 6 s following injection of contrast agent. For intravenous contrast medium injection, a 21-gauge butterfly needle was inserted into a rabbit auricular vein. Injection of 7 mL (1.5 mL/kg body weight at 1 mL/s) iso-osmolar contrast agent (Visipaque^TM 320, GE Healthcare, Wauwatosa, WI) was followed by saline flush (5 mL at 1 mL/s). The injection of contrast medium facilitated delineation of tumour vascularity.

Attaluri A., Seshadri M., Mirpour S., Wabler M., Marinho T., Furqan M., Zhou H., De Paoli S., Gruettner C., Gilson W., DeWeese T., Garcia M., Ivkov R, & Liapi E. (2016). Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 32(5), 543-557.

+ Open protocol

+ Expand

High-Resolution CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

The ten colon segments were scanned on a 640-slice CT scanner (Acquilion ONE; Toshiba Medical System, Tochiki-ken, Japan) with tube voltage of 120 kVp, and current doses of 10 mAs, 20 mAs, 30 mAs, 40 mAs, 50 mAs, respectively. The imaging parameters are 500 ms rotation time, 0.5 mm × 640 slice collimation, 0.875 pitch, 512 × 512 matrix, and 400 mm field of view. The original image data were transferred to an image postprocessing workstation (Vitrea, Version 6.2; Toshiba Medical System, Tochiki-ken, Japan) via picture archiving and communication system.

Shen H., Liang D., Luo M., Duan C., Cai W., Zhu S., Qiu J, & Li W. (2015). Pilot Study on Image Quality and Radiation Dose of CT Colonography with Adaptive Iterative Dose Reduction Three-Dimensional. PLoS ONE, 10(1), e0117116.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!